Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Hideaki Kise"'
Autor:
Hideaki Kise
Publikováno v:
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology. 112(2)
The patient was a 78-year-old man who, at 67 years of age, had been diagnosed with prostate cancer cT3bN1M0 (Gleason score 5+5) and started on androgen ablation therapy. Thereafter, the cancer had developed into castration-resistant prostate cancer;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf9802126093562384e091de5ff49228
https://pubmed.ncbi.nlm.nih.gov/35444080
https://pubmed.ncbi.nlm.nih.gov/35444080
Autor:
Hideaki Kise
Publikováno v:
Kampo Medicine. 71:204-212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33bcd393c544c7933f2bff5253d61dcd
https://doi.org/10.3937/kampomed.71.204
https://doi.org/10.3937/kampomed.71.204
Autor:
Hideaki, Kise, Taizo, Shiraishi
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 67(3)
A 56-year-old man visited our hospital with a chief complaint of worsening urinary pain after a treatment by another doctor. Prostate specific antigen (PSA) was 429.66 ng/ml, and computed tomography (CT) revealed multiple lymph node enlargement and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5084a06c5687de589bca609c3c3ec334
https://pubmed.ncbi.nlm.nih.gov/33957032
https://pubmed.ncbi.nlm.nih.gov/33957032
Autor:
Kiminobu Arima, Yoshiki Sugimura, Yoichi Iwamoto, Kenichiro Ishii, Hideki Kanda, Yasuhide Hori, Hideaki Kise, Norihito Soga, Kohei Nishikawa
Publikováno v:
Cancer Prevention Research. 4:87-96
In prostate cancer, tumor–stroma interactions play a critical role in the promotion of tumorigenesis, and thus the prevention of those interactions is a promising target to suppress tumor growth. Several studies demonstrated that alpha1-adrenocepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b48aa7824b860479b49a5193ff003dd6
https://doi.org/10.1158/1940-6207.capr-10-0189
https://doi.org/10.1158/1940-6207.capr-10-0189
Autor:
Hideaki Kise, Yuko Yoshio, Kenichiro Ishii, Norihito Soga, Kohei Nishikawa, Yasuhide Hori, Shigeki Arase, Yoshiki Sugimura, Kiminobu Arima
Publikováno v:
Differentiation. 80:82-88
Transforming growth factor-α (TGFα) promotes cell proliferation by binding to the epidermal growth factor receptor (EGFR). TGFα and EGFR overexpression have been reported in various human cancers. However, whether TGFα induces cancer by itself is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32cc2cf35fdefa507963dbd13a19022
https://doi.org/10.1016/j.diff.2010.06.006
https://doi.org/10.1016/j.diff.2010.06.006
Publikováno v:
International Journal of Clinical Oncology. 15:376-381
To evaluate the efficacy and toxicity of third-line gemcitabine monotherapy (Gem) in patients with platinum-resistant advanced urothelial cancer (UC).From July 2005 to March 2009, 13 patients were enrolled. All patients had previously received methot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7d61dd087a21324c473beecc249ea08
https://doi.org/10.1007/s10147-010-0071-8
https://doi.org/10.1007/s10147-010-0071-8
Autor:
Yasushi Yamada, Hideaki Kise, Norihito Soga, Kiminobu Arima, Yoshiki Sugimura, Yoshihiro Hasegawa, Kouhei Nishikawa
Publikováno v:
International Journal of Urology. 16:576-579
The objective of this study was to evaluate the efficacy and toxicity of combined gemcitabine and capecitabine (Gca) chemotherapy in patients with advanced renal cell cancer after immunotherapy failure. Nine patients were enrolled in this trial. Gemc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf2fe19202d318bcf203e7ac3d06bb6c
https://doi.org/10.1111/j.1442-2042.2009.02308.x
https://doi.org/10.1111/j.1442-2042.2009.02308.x
Autor:
Kiminobu Arima, Yoshihiro Hasegawa, Yasushi Yamada, Hideaki Kise, Kouhei Nishikawa, Norihito Soga, Yoshiki Sugimura, Manabu Kato
Publikováno v:
International Journal of Clinical Oncology. 14:130-135
We evaluated the efficacy and toxicity of intermittent docetaxel (DCT) with estramustine (EM) for hormone-refractory prostate cancer (HRPC).Fifteen patients were enrolled. They received injected DCT (70 mg/m2 body surface) on day 1 in association wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfd840860de1af231b3e4bcfb0858871
https://doi.org/10.1007/s10147-008-0814-y
https://doi.org/10.1007/s10147-008-0814-y
Autor:
Yasushi Yamada, Yoshiki Sugimura, Manabu Kato, Satoru Masui, Kouhei Nishikawa, Kiminobu Arima, Hideaki Kise, Yoshihiro Hasegawa, Norihito Soga
Publikováno v:
International Journal of Urology. 15:1018-1021
This study was designed to assess the intraoperative and postoperative benefits of two techniques for treating renal cell carcinoma (portless endoscopic surgery with radical nephrectomy [PLES-RN] and laparoscopic radical nephrectomy [LRN]) carried ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c68c293a62a6d14d79ec9fd595da5c6f
https://doi.org/10.1111/j.1442-2042.2008.02157.x
https://doi.org/10.1111/j.1442-2042.2008.02157.x
Publikováno v:
Seminars in Thrombosis and Hemostasis. 33:046-052
The kallikrein-like serine protease, prostate-specific antigen (PSA), is mixed in human seminal plasma with its protein substrates semenogelin (Sg) -I, Sg-II, and protein C inhibitor (PCI), which are produced in seminal vesicles. In the seminal plasm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab237dee43f74d2370dccb0b42fee70b
https://doi.org/10.1055/s-2006-958461
https://doi.org/10.1055/s-2006-958461